Loading…

Carlsmed, Inc.CARLCompetitor analysis, valuation and peers

United States · USD·Information Technology›Information Technology Services
Momentum leader 88
Mkt cap
$396M
US dollars, full cap
Free float
37%
of shares outstanding
$/day
$1.18M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-195.6 pp
WACC 14.2%
Hurdle
n/a
no reverse DCF
Next earnings
4 days
10 Nov 2026
Close · USD$14.52
1D-5.2%
1W-2.9%
1M+3.4%
3M+5.8%
6M+48.2%
YTD+17.6%
1Y+20.0%
ATR %6.5%
Beta1.32
52w lowhigh15.7% off high

What Carlsmed does

Employees: 127

Carlsmed at a glance

Size Carlsmed (CARL) is a United States Information Technology company (Information Technology Services) with a market value of $396M, the 2865th largest of 3,117 United States companies the cockpit tracks. Shares closed at $14.52 on 6 Nov 2026.

Performance Over six months the shares gained 48.2%, against -11.4% for the median peer and -1.1% for the United States market (cap-weighted) — 2nd highest of 21 in its peer set.

Growth Revenue grew 65.4% over the last twelve months (peer median +8.2%); the operating margin is -61.1% (peer median 8.5%).

Valuation It trades at 5.2× enterprise value to sales against a peer median of 1.6× (4th most expensive of 20).

Capital Return on invested capital runs 195.6 points below its cost of capital (14.2% WACC).

Short interest Short interest is 4.0% of the free float (15 Oct 2026).

Next results Next results expected around 10 Nov 2026 (exchange calendar; dates can move).

Relative performance

10015011 May 202611 Aug 20266 Nov 2026CARL 150Peer median 89
Six months, rebased to 100: Carlsmed against the median of its 20 peers (local-currency closes).

Carlsmed financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023
Revenue$63.3M$50.5M$27.2M$13.8M
Revenue growth—+86%+97%—
Gross profit$48.5M$38.0M$20.0M$9.90M
EBITDA-$38.3M-$30.3M-$24.0M-$18.5M
Net income-$36.3M-$29.6M-$24.3M-$18.9M
Free cash flow-$34.6M-$29.6M-$25.6M-$17.6M
Capital expenditure$1.53M$1.36M$180,000$135,000
Total debt$21.9M$17.4M$17.2M$11.4M

Quarterly statements and history in the cockpit →

Carlsmed competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-10%0%+10%0022488157CINT3000512158688500IXX6882923661969230057844313012084832CMPTLSSWP3854ALC3817CARL6-month return →1-month return →
Up and to the right = strong over both horizons. Carlsmed is the large dot.

Fundamentals: revenue growth against valuation

-50%0%+50%0×10×0022488157CINT300051688500IXX68829230057844313012084832CMPTLSSWP3817CARLRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Carlsmed is the large dot.

Carlsmed competitors and peer comparison

How Carlsmed compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Carlsmed against its 20 peers (data as of 6 Nov 2026)
MeasureCARLPeer medianRank in peer set
1-month return+3.4%-5.3%6th highest of 21
6-month return+48.2%-11.4%2nd highest of 21
Distance from 52-week high-15.7%-32.7%5th highest of 21
Revenue growth (TTM)+65.4%+8.2%2nd highest of 21
Operating margin-61.1%8.5%2nd lowest of 21
EV / Sales5.2×1.6×4th most expensive of 20
ROIC minus cost of capital-195.6 pp+5.0 pplowest of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Carlsmed CARLUnited States$396M+48%+65%-61%5.2×n/an/a
Weihai Huadong Automation 002248.SZChina$396M-34%+1%8%7.9×36.8%+10.1%
Tsuzuki Denki 8157.TJapan$395M+9%+8%7%0.3×-9.2%-2.9%
CI&T CINTUnited States$394M-21%+20%11%0.9×-4.4%+21.4%
Lians Technology 300051.SZChina$399M-57%-50%-114%17.7×n/an/a
Yidu Tech 2158.HKHong Kong$392M-53%+17%-11%0.9×2.9%-1.9%
HCR 688500.SSChina$391M-28%+5%-17%3.9×n/an/a
init innovation in traffic systems IXX.DEGermany$404M-37%+33%10%1.0×1.1%+12.8%
Beijing Haohan Data Technology 688292.SSChina$408M-23%+6%-12%6.0×n/an/a
m-up 3661.TJapan$413M+24%+22%16%1.6×-7.5%+20.8%
Computer Engineering & Consulting 9692.TJapan$420M+5%+18%11%0.6×-18.5%+6.5%
BizConf Technology 300578.SZChina$373M-41%-3%-13%5.0×n/an/a
Smaregi 4431.TJapan$421M+42%+21%26%4.2×-3.2%+32.0%
ChinaEtek Service and Technology 301208.SZChina$369M-25%+47%3%1.1×n/an/a
JFE Systems 4832.TJapan$369M-2%-14%11%0.6×-19.0%+4.3%
Comp CMP.WAPoland$427M+64%+7%11%1.8×6.0%+3.3%
Telos TLSUnited States$360M+8%+66%-2%1.6×-2.3%-1.7%
Sword SWP.PAFrance$360M+4%+8%9%1.1×-0.1%+11.0%
I'LL 3854.TJapan$357M-6%+8%27%2.3×-11.5%+9.6%
Altia Consultores ALC.MCSpain$444M-17%+23%8%n/an/an/a
SRA 3817.TJapan$352M0%-5%16%0.7×-20.2%+6.2%

Questions

Which companies are Carlsmed's closest peers?
The cockpit's peer set: Weihai Huadong Automation (002248.SZ), Tsuzuki Denki (8157.T), CI&T (CINT), Lians Technology (300051.SZ), Yidu Tech (2158.HK), HCR (688500.SS), init innovation in traffic systems (IXX.DE), Beijing Haohan Data Technology (688292.SS).
Is Carlsmed expensive compared with its peers?
On ev / sales it trades at 5.2× against a peer median of 1.6×, 4th most expensive of 20 in its peer set.
How has Carlsmed stock performed?
Over six months to 6 Nov 2026 the shares returned +48.2% against -11.4% for the median peer; over one year +20.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.